ArticleERJ open research2021

Efficacy and safety of single-inhaler triple therapy of glycopyrronium, formoterol and fluticasone in patients with COPD: a double-blind, randomised controlled trial.

Sundeep Salvi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.